Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today
Procter & Gamble (NYSE:PG | PG Price Prediction) is the household name every retirement portfolio reaches for when markets get choppy, and its $350.4 billion market cap makes it the default consumer defensive trade on every desk. The internals tell…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Procter & Gamble (NYSE:PG | PG Price Prediction) is the household name every retirement portfolio reaches for when markets get choppy, and its $350.4 billion market cap makes it the default consumer defensive trade on every desk.
The internals tell a different story.
The Crowded Trade Is Quietly Cracking
P&G beat its most recent quarter, but the internals are softening under the polish. Management guided fiscal 2026 results toward the lower end of a $6.83 to $7.09 core EPS range while absorbing a $400 million after-tax tariff headwind and a $100 million commodity hit. Volume has gone quiet in Oral Care, Fabric Care, and Family Care, and the recent top-line gains have leaned on pricing and mix rather than units moving off shelves. That is the exact setup that invites private-label trade-downs when consumer budgets tighten, a risk flagged directly in the organic volume versus pure pricing dynamic going into 2026.
The valuation does not pay you to wait through that. PG trades at a trailing PE of 22 with a 2.85% yield, and shares are down 3.46% over the past year while the broader market has run. This is the crowded mega-cap defensive trade, and the room is full.
The Cash-Flow Powerhouse Already Delivering
Colgate-Palmolive (NYSE:CL) just posted its fourth consecutive EPS beat, delivering adjusted EPS of $0.97 against a $0.9445 consensus, on revenue of $5.324 billion that grew 8.41% year over year. Shares are up 16.06% year to date while PG has lagged. Three reasons this gap widens from here.
1. The cash flow is accelerating. Operating cash flow jumped 24.5% to $747 million in Q1 2026, and free cash flow climbed 27.94% to $609 million. Full-year 2025 generated $3.634 billion in free cash and returned $3.033 billion to shareholders. The 60.6% gross profit margin gives Colgate the cushion to absorb input inflation without crimping earnings power.
2. International volume is doing the heavy lifting. Latin America revenue grew 14.8%, Europe 11.9%, and Asia Pacific 8.9%, with emerging markets posting 6.2% organic growth on 3.5% volume gains. Colgate holds 41.1% of the global toothpaste market and 32.6% of manual toothbrushes. The growth engine runs through international markets, away from the U.S. consumer exposure that weighs on PG.
3. Dividend Aristocrat status with room to run. Colgate is a 63-year Dividend Aristocrat, just lifted the quarterly payout to $0.53, and is executing a Strategic Growth and Productivity Program targeting $200 to $300 million in annual pretax savings. At a $72.5 billion market cap with a forward PE of 23, the runway is wider than the crowded trade above it.
CEO Noel Wallace framed the setup plainly: “We delivered a strong start to 2026, with broad-based top and bottom-line growth. Net sales and organic sales grew in every category and in four of five divisions with a nice balance of volume and pricing growth.”
The Action
Colgate-Palmolive belongs on the short list of defensive holdings worth researching this week.
Contact [email protected] for any questions or corrections.







